Next-Generation Sequencing in Solid Tumors
Chen, PharmD, MS, BCOP, CPP, discusses the role of next-generation sequencing (NGS) in biomarker testing and treatment planning for solid tumors.
- NGS improves biomarker testing
- Enhances treatment planning in solid tumors
Expert insights from Traina, MD, FASCO, and other specialists highlight the benefits of NGS in oncology.
Specialists including Demetria Smith-Graziani, MD, MPH, Mark Agulnik, MD, and others share their perspectives on the application of NGS in solid tumor treatment.
Author's summary: NGS streamlines biomarker testing in solid tumors.